本公司為日本 Rion Particle Couuter 台灣、中國代理商,專業、完善的售後服務與訓練。嬴得半導體廠或相關廠商一致好評,期待有熱忱和上進之人士加入我們。
1.1998年10月:總公司創立於新竹縣竹北市
2.2001年9月:上海辦事處成立
3.2002年10月:取得ISO9001:2000認證.certificate NO:3594
本公司為日本 Rion Particle Couuter在台灣及大陸之總代理,為了提供專業的售後服務,再兩地共斥資新台幣玖百萬元整成立Taiwan Servic Center & China Service Center
奈捷生物科技(Instant NanoBiosensors),是精準醫療診斷領域的先驅,全球研發總部位於南港國家生技園區,在美國San Francisco設有商務拓展實驗室,荷蘭Utrecht設有歐洲子公司,台灣汐止廠設有ISO 13485/ QMS生產線,在兩大領域展現了本公司在全球的影響力:
在基因檢測領域,我們憑藉著創新的專有檢測設備和試劑,引領「下一代基因檢測革命」。這使醫院能夠實施精準的內部醫療診斷,並根據個人健康管理和治療需求提供快速、準確的診斷報告。
我們的蛋白質檢測部門專注於阿茲海默症血液生物標記檢測的尖端技術,並在此領域取得了重大的國際進展。我們與知名生技公司密切合作,共同開發突破性的阿茲海默症診斷技術。
在歐盟倡議的支持下,以及比爾蓋茲支持的阿茲海默症藥物發現基金會(the Alzheimer's Drug Discovery Foundation) 的資助下,我們正在拓展市值 150 億美元的阿茲海默症檢測市場,提供全球前景並推動醫療保健的可能性。
Instant NanoBiosensors is a pioneer in precision medical diagnostics. With its global R&D headquarters in National Biotechnology Research in Nangang, a business development laboratory in San Francisco, the United States, a European subsidiary in Utrecht, the Netherlands, and an ISO 13485/QMS production line in Xizhi, Taiwan, the company has demonstrated its global influence in two major areas:
In the field of genetic testing, we lead the "Next-Generation Genetic Testing Revolution" with our innovative suite of proprietary testing equipment and reagents. This empowers hospitals to implement precise in-house medical diagnostics, delivering swift, accurate diagnostic reports tailored to individual health management and treatment needs.
Our protein testing division focuses on cutting-edge technology for blood biomarker detection of Alzheimer's disease, where we have achieved significant international advancements. Collaborating closely with renowned biotechnology firms, we are jointly developing groundbreaking Alzheimer's diagnostics.
Supported by initiatives from the European Union and funding from the Alzheimer's Drug Discovery Foundation, backed by Bill Gates, we are spearheading the $15 billion Alzheimer's detection market, offering global prospects and advancing healthcare possibilities.
International Media Interview:
*2025 年7月數位時代 Business Next Media專訪https://podcasts.apple.com/tw/podcast/ep110-%E5%BE%9E%E5%A5%88%E7%B1%B3%E9%87%91%E5%88%B0%E5%85%A8%E7%90%83%E9%86%AB%E6%9D%90%E5%B8%82%E5%A0%B4-%E5%A5%88%E6%8D%B7%E7%94%9F%E6%8A%80%E7%9A%84%E5%89%B5%E6%96%B0%E8%B7%AF%E5%BE%91-%E5%B0%88%E8%A8%AA%E5%A5%88%E6%8D%B7%E7%94%9F%E6%8A%80%E5%89%B5%E8%BE%A6%E4%BA%BA%E6%9A%A8%E8%91%A3%E4%BA%8B%E9%95%B7-%E9%8D%BE%E5%B0%8A%E6%99%BA-tony/id1684684945?i=1000716613634
*2025 年6月環球生技專訪
https://news.gbimonthly.com/tw/article/show.php?num=77933
https://news.gbimonthly.com/tw/article/show.php?num=77834
*2021 年7月科技部 TTA季刊專訪http://www.instantnano.com/contents/news?id=45 *2020年8月『商業周刊』專訪 https://www.businessweekly.com.tw/Archive/Article?StrId=7002224
*2020年7月環球生技月刊新銳公司專訪 https://www.gbimonthly.com/2020/08/78143/
*2020 年1月 Merck Innovation Center 官網報導 https://reurl.cc/XWKLbM *2020 年1月 Journal Publication in EE Times Asia:Detecting Biomarkers With Optical-Fiber https://www.eetasia.com/news/article/Detecting-Biomarkers-With-Optical-Fiber